Registro

Enigma Healthcare Ltd's Climate Report

Submitted on 2026-06-17
| Edited on 2026-06-17

Introduction *

Commitment and Targets *

Own Emissions *

Value Chain Emissions *

(optional)

Climate Solutions *

(optional)

Governance, Strategy and Climate Risk *

(optional)

Results, Challenges and Outlook *

Version 3.0

Introduction *

1.1 End day of the reporting period

*
2026-12-31

1.1.1 Año de informe

*
2026

1.2 Describe your business activities

*
Enigma Healthcare is a CQC-registered independent community clinic delivering outpatient services for NHS and private clients across England and Wales. Its ESG Strategy aligns with its mission of “right care at the right time – closer to home” and embeds ESG through ISO9001/ISO14001-certified management systems, a Net Zero pathway and social value commitments.

1.4 Number of employees on the end day of the reporting period

*
22

1.4.1 Full-time equivalent (FTE) or headcounts

*
Full-time equivalent

1.5 Is this report being submitted on behalf of a parent company or a subsidiary? If so, please briefly explain the relationship.

*
Not applicable

Commitment and Targets *

2.1 Net zero target year

*
2025

2.1.1 Base year

*
2024

2.1.2 Base year value

*
10.3

2.2 Near-term target

*

50% of intensity scope 1+2+3 emission reduction from my base year by 2030

2.3 Provide any additional comments or context on your net zero and near term targets.

*
Enigma Healthcare achieved stable total emissions of 10.3 tCO2e in 2025 while clinical activity increased by 23%, reducing carbon intensity per treatment by approximately 19%. Scope 3 data quality and supplier engagement will continue to be improved.

2.4 To reduce emissions in line with my commitment, my company has a climate action plan and is taking action

*
Yes, the plan and action include all scope 1+2+3

Own Emissions *

Energy consumption

3.2 Total energy consumption

*
27543 kWh

3.3 Total renewable energy consumption

*
17010 kWh

Scope 1 emissions

3.4 Scope 1 emissions

*
2.3 metric tons CO2e

Scope 2 emissions

3.5 Location-based scope 2 emissions

*
0 metric tons CO2e

3.6 Market-based scope 2 emissions

*
0 metric tons CO2e

3.7 Have you taken any actions to reduce scope 1+2 emissions in the reporting period?

*
Yes

3.7.1 What actions have you taken to reduce scope 1+2 emissions in the reporting period

*

Climate strategy and planning,Switch to renewable electricity,Energy efficient buildings and offices,Material circularity and waste reduction,Other company behavioural changes

3.7.2 Provide any additional details

*
During the reporting period Enigma Healthcare maintained 100% renewable electricity supply, actively monitored and optimised energy use, reduced Scope 1 emissions by approximately 12%, and used the ESG Strategy/Net Zero roadmap to identify further actions including climate clauses in the IMS, behaviour-change education, low-carbon heating feasibility, and solar-control window film to reduce heating/cooling demand.

3.8 Which tools or methods did you use to calculate your scope 1+2 emissions?

*

Other (please specify)

3.8.1 Specify any additional details

*
SME Climate Hub tools; GHG Protocol Corporate Accounting Standard; UK DEFRA emission factors; internal ESG audit and review

Value Chain Emissions (optional) *

Scope 3 emissions

4.1 Have you measured any of your scope 3 emissions?

*
No

Supply chain related - upstream emissions

Customer related - downstream emissions

4.2 Have you taken any actions to reduce scope 3 emissions in the reporting period?

*
Yes

4.2.1 What actions have you taken to reduce scope 3 emissions in the reporting period?

*

Climate strategy and planning,Switch to renewable electricity,Energy efficient buildings and offices,Business travel and commuting,Supply chain engagement,Material circularity and waste reduction,Other company behavioural changes

4.2.2 Provide any additional details

*
Enigma Healthcare strengthened supplier ESG screening, embedded sustainability criteria into procurement, maintained 100% landfill diversion, introduced segregated recycling/circular economy initiatives, and is expanding Scope 3 reporting to staff travel and wider lifecycle emissions. The live ESG register tracks the Supplier Account Form extension to full ESG, 2028 supplier ESG target, reusable-device pilots, PPE glove recycling and Ambu circular-economy opportunity.

4.3 Have you asked any of your suppliers to set a net zero target (either voluntarily or as a requirement)?

*
Yes

4.3.1 What percentage of your suppliers have you asked?

*
100

4.4 Have you communicated your commitment and actions to any of your customers?

*
Yes

4.5 Which tools or methods did you use to calculate your scope 3 emissions?

*

Other (please specify)

4.5.1 Specify additional details

*
SME Climate Hub tools; GHG Protocol Corporate Accounting Standard; UK DEFRA emission factors; supplier/operational data review

Climate Solutions (optional) *

5.1 Do any of your existing products and/or services qualify as climate solutions or enabling solutions?

*

No

Governance, Strategy and Climate Risk (optional) *

6.1 What governance processes do you have in place for your climate strategy? Choose as many as are applicable.

*

Governance process in place

6.1.3 Please describe the governance process in place

*
The ESG governance process uses a Plan-Do-Check-Act model supported by the live ESG Performance & Improvement Register, quarterly internal audit template, RAID log and regulatory compliance obligations register. ESG is Board-owned, Tiger Team-led, assigned to named owners, and embedded into the ISO-certified IMS as a Bedrock Policy.

6.2 Have you started to identify and assess your companies climate risks and opportunities?

*
Yes - we have identified both climate risks and opportunities

6.2.1 Where are the climate risks you've identified?

*
Both operations and value chains

6.2.2 How are you managing these climate risks? Choose as many as are applicable.

*

We\'ve mapped the impact of our climate risks over time (short, medium and long term horizons),We\'ve Identified plans for adaptation to mitigate these risks,We\'ve Integrated these adaptation plans into business practices

6.2.3 Provide any additional comments or context on your climate risks:

*
Enigma Healthcare assesses climate risks through the ESG Strategy, Net Zero roadmap and live ESG register. Current controls/actions include adding climate clauses/risk to the ISO IMS, maintaining 100% renewable electricity, monitoring utility trends, managing heat/cold/flood considerations, exploring low-carbon heating and solar-control window film, extending supplier ESG screening, reducing waste and single-use plastics, and developing staff/supplier emissions data.

6.3 Have you integrated climate and/or nature into your company mission statement or shareholder agreements? If yes, describe how.

*

No

-

6.4 Have you taken actions this year outside of your emissions to accelerate climate progress?

*

No

-

Results, Challenges and Outlook *

7.1 Provide any additional comments or context on your annual results and progress from previous years.

*
In 2025 Enigma Healthcare maintained total emissions at 10.3 tCO2e while clinical activity increased by 23%, reducing carbon intensity per treatment by approximately 19%. The live ESG register now tracks progress against the SBTi-aligned Net Zero roadmap, climate clauses in IMS, supplier ESG screening, waste/recycling targets, water conservation, apprenticeships, volunteering and community education actions.

7.2 Do you face any key challenges in reducing emissions?

*

Reducing scope 3 emissions,Complexities in managing supply chain emissions,Time constraints,Inaccurate or insufficient data,Low return on investment

7.3 Has there been any third party validation of the data submitted in this report?

*

Yes

Key challenges are expanding Scope 3 measurement, improving supplier and lifecycle emissions data, adding staff commuting/travel categories, continuing to decouple emissions from growth in clinical activity, developing practical business cases for estate measures such as renewable heat and window-film efficiency improvements, resolving Citation full-ESG audit-scope delays, and sustaining staff engagement with ESG behaviour change.

Enigma Healthcare Ltd's Climate Report

Enigma Healthcare Ltd's Climate Report - 2026

Introduction *

1.1 End day of the reporting period

*
2026-12-31

1.1.1 Año de informe

*
2026

1.2 Describe your business activities

*
Enigma Healthcare is a CQC-registered independent community clinic delivering outpatient services for NHS and private clients across England and Wales. Its ESG Strategy aligns with its mission of “right care at the right time – closer to home” and embeds ESG through ISO9001/ISO14001-certified management systems, a Net Zero pathway and social value commitments.

1.4 Number of employees on the end day of the reporting period

*
22

1.4.1 Full-time equivalent (FTE) or headcounts

*
Full-time equivalent

1.5 Is this report being submitted on behalf of a parent company or a subsidiary? If so, please briefly explain the relationship.

*
Not applicable

Commitment and Targets *

2.1 Net zero target year

*
2025

2.1.1 Base year

*
2024

2.1.2 Base year value

*
10.3

2.2 Near-term target

*

50% of intensity scope 1+2+3 emission reduction from my base year by 2030

2.3 Provide any additional comments or context on your net zero and near term targets.

*
Enigma Healthcare achieved stable total emissions of 10.3 tCO2e in 2025 while clinical activity increased by 23%, reducing carbon intensity per treatment by approximately 19%. Scope 3 data quality and supplier engagement will continue to be improved.

2.4 To reduce emissions in line with my commitment, my company has a climate action plan and is taking action

*
Yes, the plan and action include all scope 1+2+3

Own Emissions *

Energy consumption

3.2 Total energy consumption

*
27543 kWh

3.3 Total renewable energy consumption

*
17010 kWh

Scope 1 emissions

3.4 Scope 1 emissions

*
2.3 metric tons CO2e

Scope 2 emissions

3.5 Location-based scope 2 emissions

*
0 metric tons CO2e

3.6 Market-based scope 2 emissions

*
0 metric tons CO2e

3.7 Have you taken any actions to reduce scope 1+2 emissions in the reporting period?

*
Yes

3.7.1 What actions have you taken to reduce scope 1+2 emissions in the reporting period

*

Climate strategy and planning,Switch to renewable electricity,Energy efficient buildings and offices,Material circularity and waste reduction,Other company behavioural changes

3.7.2 Provide any additional details

*
During the reporting period Enigma Healthcare maintained 100% renewable electricity supply, actively monitored and optimised energy use, reduced Scope 1 emissions by approximately 12%, and used the ESG Strategy/Net Zero roadmap to identify further actions including climate clauses in the IMS, behaviour-change education, low-carbon heating feasibility, and solar-control window film to reduce heating/cooling demand.

3.8 Which tools or methods did you use to calculate your scope 1+2 emissions?

*

Other (please specify)

3.8.1 Specify any additional details

*
SME Climate Hub tools; GHG Protocol Corporate Accounting Standard; UK DEFRA emission factors; internal ESG audit and review

Value Chain Emissions (optional) *

Scope 3 emissions

4.1 Have you measured any of your scope 3 emissions?

*
No

Supply chain related - upstream emissions

Customer related - downstream emissions

4.2 Have you taken any actions to reduce scope 3 emissions in the reporting period?

*
Yes

4.2.1 What actions have you taken to reduce scope 3 emissions in the reporting period?

*

Climate strategy and planning,Switch to renewable electricity,Energy efficient buildings and offices,Business travel and commuting,Supply chain engagement,Material circularity and waste reduction,Other company behavioural changes

4.2.2 Provide any additional details

*
Enigma Healthcare strengthened supplier ESG screening, embedded sustainability criteria into procurement, maintained 100% landfill diversion, introduced segregated recycling/circular economy initiatives, and is expanding Scope 3 reporting to staff travel and wider lifecycle emissions. The live ESG register tracks the Supplier Account Form extension to full ESG, 2028 supplier ESG target, reusable-device pilots, PPE glove recycling and Ambu circular-economy opportunity.

4.3 Have you asked any of your suppliers to set a net zero target (either voluntarily or as a requirement)?

*
Yes

4.3.1 What percentage of your suppliers have you asked?

*
100

4.4 Have you communicated your commitment and actions to any of your customers?

*
Yes

4.5 Which tools or methods did you use to calculate your scope 3 emissions?

*

Other (please specify)

4.5.1 Specify additional details

*
SME Climate Hub tools; GHG Protocol Corporate Accounting Standard; UK DEFRA emission factors; supplier/operational data review

Climate Solutions (optional) *

5.1 Do any of your existing products and/or services qualify as climate solutions or enabling solutions?

*

No

Governance, Strategy and Climate Risk (optional) *

6.1 What governance processes do you have in place for your climate strategy? Choose as many as are applicable.

*

Governance process in place

6.1.3 Please describe the governance process in place

*
The ESG governance process uses a Plan-Do-Check-Act model supported by the live ESG Performance & Improvement Register, quarterly internal audit template, RAID log and regulatory compliance obligations register. ESG is Board-owned, Tiger Team-led, assigned to named owners, and embedded into the ISO-certified IMS as a Bedrock Policy.

6.2 Have you started to identify and assess your companies climate risks and opportunities?

*
Yes - we have identified both climate risks and opportunities

6.2.1 Where are the climate risks you've identified?

*
Both operations and value chains

6.2.2 How are you managing these climate risks? Choose as many as are applicable.

*

We\'ve mapped the impact of our climate risks over time (short, medium and long term horizons),We\'ve Identified plans for adaptation to mitigate these risks,We\'ve Integrated these adaptation plans into business practices

6.2.3 Provide any additional comments or context on your climate risks:

*
Enigma Healthcare assesses climate risks through the ESG Strategy, Net Zero roadmap and live ESG register. Current controls/actions include adding climate clauses/risk to the ISO IMS, maintaining 100% renewable electricity, monitoring utility trends, managing heat/cold/flood considerations, exploring low-carbon heating and solar-control window film, extending supplier ESG screening, reducing waste and single-use plastics, and developing staff/supplier emissions data.

6.3 Have you integrated climate and/or nature into your company mission statement or shareholder agreements? If yes, describe how.

*

No

-

6.4 Have you taken actions this year outside of your emissions to accelerate climate progress?

*

No

-

Results, Challenges and Outlook *

7.1 Provide any additional comments or context on your annual results and progress from previous years.

*
In 2025 Enigma Healthcare maintained total emissions at 10.3 tCO2e while clinical activity increased by 23%, reducing carbon intensity per treatment by approximately 19%. The live ESG register now tracks progress against the SBTi-aligned Net Zero roadmap, climate clauses in IMS, supplier ESG screening, waste/recycling targets, water conservation, apprenticeships, volunteering and community education actions.

7.2 Do you face any key challenges in reducing emissions?

*

Reducing scope 3 emissions,Complexities in managing supply chain emissions,Time constraints,Inaccurate or insufficient data,Low return on investment

7.3 Has there been any third party validation of the data submitted in this report?

*

Yes

Key challenges are expanding Scope 3 measurement, improving supplier and lifecycle emissions data, adding staff commuting/travel categories, continuing to decouple emissions from growth in clinical activity, developing practical business cases for estate measures such as renewable heat and window-film efficiency improvements, resolving Citation full-ESG audit-scope delays, and sustaining staff engagement with ESG behaviour change.
Generating a PDF file. Please wait....